GO:0003824 | catalytic activity | 43.64% (48/110) | 0.99 | 0.0 | 9.2e-05 |
GO:0071704 | organic substance metabolic process | 35.45% (39/110) | 1.14 | 1e-06 | 9.7e-05 |
GO:0044238 | primary metabolic process | 34.55% (38/110) | 1.21 | 0.0 | 0.00013 |
GO:0008152 | metabolic process | 35.45% (39/110) | 1.05 | 3e-06 | 0.000364 |
GO:0009987 | cellular process | 34.55% (38/110) | 1.04 | 5e-06 | 0.000556 |
GO:0044237 | cellular metabolic process | 26.36% (29/110) | 1.25 | 6e-06 | 0.000584 |
GO:0003674 | molecular_function | 63.64% (70/110) | 0.57 | 8e-06 | 0.000617 |
GO:0006807 | nitrogen compound metabolic process | 28.18% (31/110) | 1.16 | 1e-05 | 0.000702 |
GO:0044281 | small molecule metabolic process | 10.0% (11/110) | 2.33 | 1.3e-05 | 0.000768 |
GO:0008150 | biological_process | 48.18% (53/110) | 0.74 | 1.4e-05 | 0.000787 |
GO:0035639 | purine ribonucleoside triphosphate binding | 17.27% (19/110) | 1.48 | 4.6e-05 | 0.002074 |
GO:0044249 | cellular biosynthetic process | 11.82% (13/110) | 1.91 | 4.3e-05 | 0.002142 |
GO:0000166 | nucleotide binding | 20.0% (22/110) | 1.32 | 5.7e-05 | 0.002193 |
GO:1901265 | nucleoside phosphate binding | 20.0% (22/110) | 1.32 | 5.7e-05 | 0.002193 |
GO:1901564 | organonitrogen compound metabolic process | 22.73% (25/110) | 1.17 | 8.5e-05 | 0.002886 |
GO:1901363 | heterocyclic compound binding | 20.0% (22/110) | 1.26 | 0.0001 | 0.003018 |
GO:0044283 | small molecule biosynthetic process | 5.45% (6/110) | 3.0 | 0.000111 | 0.003025 |
GO:0017076 | purine nucleotide binding | 19.09% (21/110) | 1.32 | 8.5e-05 | 0.00306 |
GO:1901576 | organic substance biosynthetic process | 11.82% (13/110) | 1.8 | 9.6e-05 | 0.003072 |
GO:0036094 | small molecule binding | 20.0% (22/110) | 1.25 | 0.000111 | 0.003169 |
GO:0032787 | monocarboxylic acid metabolic process | 4.55% (5/110) | 3.37 | 0.000133 | 0.003434 |
GO:0018130 | heterocycle biosynthetic process | 6.36% (7/110) | 2.6 | 0.000169 | 0.004163 |
GO:0009058 | biosynthetic process | 11.82% (13/110) | 1.68 | 0.000217 | 0.005121 |
GO:1901362 | organic cyclic compound biosynthetic process | 6.36% (7/110) | 2.46 | 0.000299 | 0.006774 |
GO:0016783 | sulfurtransferase activity | 1.82% (2/110) | 6.12 | 0.000365 | 0.007338 |
GO:0046394 | carboxylic acid biosynthetic process | 4.55% (5/110) | 3.06 | 0.000354 | 0.007402 |
GO:0016053 | organic acid biosynthetic process | 4.55% (5/110) | 3.06 | 0.000354 | 0.007402 |
GO:0006082 | organic acid metabolic process | 6.36% (7/110) | 2.36 | 0.000453 | 0.007457 |
GO:0097367 | carbohydrate derivative binding | 17.27% (19/110) | 1.21 | 0.000488 | 0.007572 |
GO:0032555 | purine ribonucleotide binding | 17.27% (19/110) | 1.24 | 0.000391 | 0.007585 |
GO:0043436 | oxoacid metabolic process | 6.36% (7/110) | 2.37 | 0.000448 | 0.007603 |
GO:0043170 | macromolecule metabolic process | 22.73% (25/110) | 1.01 | 0.000485 | 0.007739 |
GO:0043168 | anion binding | 18.18% (20/110) | 1.16 | 0.000532 | 0.007813 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 11.82% (13/110) | 1.57 | 0.000448 | 0.007842 |
GO:0005524 | ATP binding | 14.55% (16/110) | 1.35 | 0.000529 | 0.007985 |
GO:0032553 | ribonucleotide binding | 17.27% (19/110) | 1.22 | 0.000442 | 0.008009 |
GO:0019752 | carboxylic acid metabolic process | 6.36% (7/110) | 2.37 | 0.000433 | 0.008106 |
GO:1901137 | carbohydrate derivative biosynthetic process | 3.64% (4/110) | 3.4 | 0.000583 | 0.008112 |
GO:0046483 | heterocycle metabolic process | 10.91% (12/110) | 1.61 | 0.000578 | 0.008254 |
GO:0005488 | binding | 41.82% (46/110) | 0.62 | 0.000656 | 0.008909 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.55% (5/110) | 2.84 | 0.000697 | 0.009228 |
GO:0140096 | catalytic activity, acting on a protein | 16.36% (18/110) | 1.19 | 0.000818 | 0.009869 |
GO:0006796 | phosphate-containing compound metabolic process | 12.73% (14/110) | 1.41 | 0.000767 | 0.009914 |
GO:0006793 | phosphorus metabolic process | 12.73% (14/110) | 1.41 | 0.000789 | 0.009966 |
GO:0030554 | adenyl nucleotide binding | 16.36% (18/110) | 1.19 | 0.000809 | 0.009978 |
GO:1901360 | organic cyclic compound metabolic process | 10.91% (12/110) | 1.54 | 0.000862 | 0.010179 |
GO:0072330 | monocarboxylic acid biosynthetic process | 2.73% (3/110) | 4.0 | 0.000902 | 0.010425 |
GO:1901135 | carbohydrate derivative metabolic process | 4.55% (5/110) | 2.75 | 0.000947 | 0.010717 |
GO:0019438 | aromatic compound biosynthetic process | 5.45% (6/110) | 2.38 | 0.001095 | 0.012129 |
GO:0034641 | cellular nitrogen compound metabolic process | 11.82% (13/110) | 1.41 | 0.001227 | 0.013329 |
GO:0097159 | organic cyclic compound binding | 27.27% (30/110) | 0.79 | 0.001409 | 0.014997 |
GO:0016787 | hydrolase activity | 15.45% (17/110) | 1.15 | 0.001531 | 0.01569 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 11.82% (13/110) | 1.38 | 0.001509 | 0.015762 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 7.27% (8/110) | 1.87 | 0.00167 | 0.016795 |
GO:0016301 | kinase activity | 10.91% (12/110) | 1.4 | 0.00197 | 0.019447 |
GO:0072521 | purine-containing compound metabolic process | 3.64% (4/110) | 2.91 | 0.002055 | 0.019923 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4.55% (5/110) | 2.46 | 0.00224 | 0.021335 |
GO:0016174 | NAD(P)H oxidase H2O2-forming activity | 0.91% (1/110) | 8.58 | 0.002607 | 0.021451 |
GO:0004641 | phosphoribosylformylglycinamidine cyclo-ligase activity | 0.91% (1/110) | 8.58 | 0.002607 | 0.021451 |
GO:0030620 | U2 snRNA binding | 0.91% (1/110) | 8.58 | 0.002607 | 0.021451 |
GO:0004076 | biotin synthase activity | 0.91% (1/110) | 8.58 | 0.002607 | 0.021451 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 0.91% (1/110) | 8.58 | 0.002607 | 0.021451 |
GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 0.91% (1/110) | 8.58 | 0.002607 | 0.021451 |
GO:0009341 | beta-galactosidase complex | 0.91% (1/110) | 8.58 | 0.002607 | 0.021451 |
GO:0005975 | carbohydrate metabolic process | 6.36% (7/110) | 1.95 | 0.002354 | 0.022042 |
GO:0072522 | purine-containing compound biosynthetic process | 2.73% (3/110) | 3.44 | 0.002738 | 0.022186 |
GO:0006725 | cellular aromatic compound metabolic process | 10.0% (11/110) | 1.45 | 0.002418 | 0.022251 |
GO:0032559 | adenyl ribonucleotide binding | 14.55% (16/110) | 1.09 | 0.003341 | 0.026291 |
GO:0006139 | nucleobase-containing compound metabolic process | 9.09% (10/110) | 1.47 | 0.003331 | 0.026599 |
GO:0016740 | transferase activity | 17.27% (19/110) | 0.96 | 0.003642 | 0.02825 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0006768 | biotin metabolic process | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0009102 | biotin biosynthetic process | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0004055 | argininosuccinate synthase activity | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0015925 | galactosidase activity | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0004049 | anthranilate synthase activity | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0044818 | mitotic G2/M transition checkpoint | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0004565 | beta-galactosidase activity | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0004001 | adenosine kinase activity | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0016882 | cyclo-ligase activity | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:0004792 | thiosulfate sulfurtransferase activity | 0.91% (1/110) | 7.58 | 0.005208 | 0.031421 |
GO:1901566 | organonitrogen compound biosynthetic process | 6.36% (7/110) | 1.79 | 0.004307 | 0.032942 |
GO:0019867 | outer membrane | 1.82% (2/110) | 4.34 | 0.004454 | 0.033592 |
GO:0043167 | ion binding | 21.82% (24/110) | 0.79 | 0.00482 | 0.034898 |
GO:0019538 | protein metabolic process | 16.36% (18/110) | 0.96 | 0.004763 | 0.03495 |
GO:0008017 | microtubule binding | 2.73% (3/110) | 3.16 | 0.00475 | 0.035329 |
GO:0015631 | tubulin binding | 2.73% (3/110) | 3.03 | 0.006076 | 0.036257 |
GO:0051274 | beta-glucan biosynthetic process | 1.82% (2/110) | 4.06 | 0.006469 | 0.037773 |
GO:0006468 | protein phosphorylation | 9.09% (10/110) | 1.34 | 0.006436 | 0.037988 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0019206 | nucleoside kinase activity | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0009163 | nucleoside biosynthetic process | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0005094 | Rho GDP-dissociation inhibitor activity | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0006166 | purine ribonucleoside salvage | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0004316 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0042278 | purine nucleoside metabolic process | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0042451 | purine nucleoside biosynthetic process | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0046128 | purine ribonucleoside metabolic process | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0042455 | ribonucleoside biosynthetic process | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:1901659 | glycosyl compound biosynthetic process | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0046129 | purine ribonucleoside biosynthetic process | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0043174 | nucleoside salvage | 0.91% (1/110) | 7.0 | 0.007802 | 0.038512 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 1.82% (2/110) | 4.03 | 0.006746 | 0.038556 |
GO:0051273 | beta-glucan metabolic process | 1.82% (2/110) | 4.03 | 0.006746 | 0.038556 |
GO:0016782 | transferase activity, transferring sulphur-containing groups | 1.82% (2/110) | 3.91 | 0.007902 | 0.038658 |
GO:0016310 | phosphorylation | 9.09% (10/110) | 1.32 | 0.006908 | 0.039073 |
GO:0009150 | purine ribonucleotide metabolic process | 2.73% (3/110) | 2.85 | 0.00859 | 0.041647 |
GO:0004672 | protein kinase activity | 9.09% (10/110) | 1.3 | 0.007567 | 0.042361 |
GO:0019725 | cellular homeostasis | 1.82% (2/110) | 3.8 | 0.009142 | 0.04393 |
GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.82% (2/110) | 3.78 | 0.009465 | 0.045081 |
GO:0030870 | Mre11 complex | 0.91% (1/110) | 6.58 | 0.010389 | 0.045493 |
GO:0000427 | plastid-encoded plastid RNA polymerase complex | 0.91% (1/110) | 6.58 | 0.010389 | 0.045493 |
GO:0042770 | signal transduction in response to DNA damage | 0.91% (1/110) | 6.58 | 0.010389 | 0.045493 |
GO:0000077 | DNA damage checkpoint signaling | 0.91% (1/110) | 6.58 | 0.010389 | 0.045493 |
GO:0004148 | dihydrolipoyl dehydrogenase activity | 0.91% (1/110) | 6.58 | 0.010389 | 0.045493 |
GO:0017069 | snRNA binding | 0.91% (1/110) | 6.58 | 0.010389 | 0.045493 |
GO:0140535 | intracellular protein-containing complex | 2.73% (3/110) | 2.73 | 0.010613 | 0.045738 |
GO:0003924 | GTPase activity | 2.73% (3/110) | 2.73 | 0.010613 | 0.045738 |
GO:0009259 | ribonucleotide metabolic process | 2.73% (3/110) | 2.78 | 0.009805 | 0.045899 |
GO:0009250 | glucan biosynthetic process | 1.82% (2/110) | 3.75 | 0.009792 | 0.046236 |
GO:1902494 | catalytic complex | 3.64% (4/110) | 2.25 | 0.01032 | 0.04749 |
GO:0036211 | protein modification process | 10.91% (12/110) | 1.08 | 0.011161 | 0.047718 |
GO:0019693 | ribose phosphate metabolic process | 2.73% (3/110) | 2.75 | 0.010286 | 0.047736 |